Investor Resources

Heron Therapeutics Q4 2023 Conference Call
03/12/2024 at 4:30 pm EDT
At Heron, we are unwavering in our commitment to improve the lives of patients. We aim to advance the therapeutic standard of care for patients through a portfolio of best-in-class therapies that bring together our innovative science and technologies with well-known pharmacology to deliver medicines that matter.

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Sign-Up for Email Updates

Receive news and updates on Heron’s latest innovations.